We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Novel Ultrasound Technology Using AI Algorithms Has Potential to Achieve 100 Times Greater Sensitivity

By MedImaging International staff writers
Posted on 25 Oct 2021
Print article
Illustration
Illustration

A novel ultrasound technology, using patented hardware, software, and artificial intelligence (AI) algorithms could deliver 100 times higher sensitivity than other ultrasound systems in the market.

DeepSight Technology (San Francisco, CA, USA) is augmenting diagnostic medical imaging with the introduction of its novel ultrasound technology that improves ultrasound image quality and more than doubles the effective range when compared to conventional technologies.

DeepSight’s solution incorporates patented hardware, software and AI technologies that vastly improve image quality and extend the depth penetration of medical diagnostic ultrasound - unleashing its full potential. DeepSight imaging solutions are expected to broaden the realm of applications where existing ultrasound technology has been limited and would otherwise require unsafe, more costly and less accessible imaging modalities such as CT or MRI. It aims to improve the speed, range and accuracy of imaging and diagnosis across a range of applications.

Whether for abdominal, breast, or obstetrical applications, there is a need for better image clarity at depths well beyond the range of today’s state-of-the-art scanners. Better sensitivity can help with the identification of masses hard to see with conventional ultrasound. The visualization of tumor structure and blood flow to differentiate between malignant and benign tumors and the ability to accurately assess treatment response can help reduce the need for other diagnostic and interventional methods. DeepSight’s vision is to provide the clarity needed for fast and accurate diagnoses and avoid the need for additional imaging.

"We are excited to be on the frontier of advancing medical imaging," said founder and CEO Nader Sadrzadeh. "Based on internal studies, our technology has the potential to achieve 100 times greater sensitivity, ultimately allowing us to deliver better patient care."

Related Links:
DeepSight Technology 

New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Imaging Table
CFPM201
New
Gold Member
X-Ray QA Meter
T3 RG Pro
New
Table-Top Reader
FCR PRIMA T2

Print article
Radcal

Channels

MRI

view channel
Image: MRI-linac allows clinicians to see what’s going on in the brain for the first time (Photo courtesy of Sylvester Comprehensive Cancer Center)

MRI Provides Early Warning System for Glioblastoma Growth

A new study has demonstrated the potential of combining imaging with radiation to shape glioblastoma treatment in real time. The research is the first to quantify tumor changes in glioblastoma patients... Read more

Nuclear Medicine

view channel
Image: A new biomarker makes it easier to distinguish between Alzheimer’s and primary tauopathy (Photo courtesy of Shutterstock)

Diagnostic Algorithm Distinguishes Between Alzheimer’s and Primary Tauopathy Using PET Scans

Patients often present at university hospitals with diseases so rare and specific that they are scarcely recognized by physicians in private practice. Primary 4-repeat tauopathies are a notable example.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Focused ultrasound therapy is poised to become an essential tool in every hospital, cancer care center and physician office (Photo courtesy of Arrayus)

Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer

Pancreatic cancer remains one of the most difficult cancers to treat due to its dense tissue structure, which limits the effectiveness of traditional drug therapies. Bracco Imaging S.A. (Milan, Italy)... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.